In order to gain insight into the functional mechanisms that could trigger said increased exhaustion of CD8+ T cells, we compared the effect on T cells of malignant B-CLL cells obtained from patients at clinical progression vs. malignant cells from patients at follow-up of stable disease (non-progression). The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.